NCT07236671 Progression Patterns of Choroidal Venous Alterations
| NCT ID | NCT07236671 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Singapore National Eye Centre |
| Condition | Pachychoroid Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-03-04 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2025-03-04 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is about understanding how a condition called pachychoroid changes over time. Pachychoroid refers to an anatomic choroidal characteristic with abnormally thick choroid or abnormally dilated Haller's vessels. Pachychoroid can range from mild forms which does not cause any problems to more serious ones that might cause vision loss.This study will recruit participants with pachychoroid, to learn more about how this condition develops, how it affects people in the long run, and what factors might make it worse.
Eligibility Criteria
Inclusion Criteria: 1. Adults aged 45 years or older. 2. Presence of pachyvessels on ultra-widefield (UWF) imaging in at least one quadrant. 3. Willing to undergo pupil dilation, and protocol-required procedures for both eyes 4. Willing to provide written informed consent Exclusion Criteria: 1. Presence of disorders of the ocular media which interfere with visual acuity and other ocular assessments during the study period 2. Eyes with other ocular pathology such as trauma, inflammation, previous intraocular surgery (except for cataract surgery) 3. Systemic diseases that might affect ocular blood flow such as uncontrolled hypertension, autoimmune disease, and haematological disorders 4. Pregnant or nursing women 5. Persons who are unable to give informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07236671 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Pachychoroid Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07236671 currently recruiting?
Yes, NCT07236671 is actively recruiting participants. Contact the research team at gemmy.cheung.c.m@singhealth.com.sg for enrollment information.
Where is the NCT07236671 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Kuala Lumpur, Malaysia, Singapore, Singapore, Singapore, Singapore.
Who is sponsoring the NCT07236671 clinical trial?
NCT07236671 is sponsored by Singapore National Eye Centre. The trial plans to enroll 250 participants.